NeuroTrials Research is conducting a research study to determine the efficacy of an investigational drug.

Qualified participants receive all study-related exams and study drug at no cost. Compensation is available for time and travel.

You may qualify if you:
•are 18-55.
•have been diagnosed with MS.
•have experienced either a worsening of MS symptoms or new symptoms.
•do not have a diagnosis of primary progessive MS.
•have no other neurological disorders.

Click here for more info.

If you are interested in participating in this study, please CONTACT US.

How can you help with Parkinson's Disease?

NeuroTrials Research is conducting a study on the efficacy of a new study drug for patients with moderate to severe Parkinson’s Disease.

You may qualify if you:
•are 30 to 85
•are in general good health
•experience slowness in movement
•experience muscle rigidity or resting tremors
•have been receiving a stable dose of L-Dopa for over a year

Click here for more info. 

If you are interested in participating in this study, please CONTACT US.

If you suffer from epilepsy, you may be eligible to participate in a clinical study of an investigational drug for partial onset seizures.
Qualified participants must be:
•17-65 years old
•Diagnosed with epilepsy for at least 1 year
•In overall good health
•Currently taking antiepileptic medication

Click here for more info
If you are interested in participating in this study, please CONTACT US.

NeuroTrials Research is conducting a 20-month, placebo-controlled research study evaluating an investigational drug for Alzheimer’s Disease.

Study-related exams and study drug are provided at no cost. Qualified participants & caregivers will be compensated for time and travel. To qualify, participants must:



-be 50-89 years of age.

-have a diagnosis of probable Alzheimer’s Disease.

-have a caregiver capable of attending all -study visits.

-otherwise be in general good health.

Click here for more info
If you are interested in participating in this study, please CONTACT US.

Writhing and Rolling from Restless Legs?

NeuroTrials Research is conducting a local study to examine the safety and efficacy of a new investigational drug for Restless Legs Syndrome.

You may qualify if you:
•are 18-70 years of age.
•have a history of RLS for over 6 months.
experience symptoms of RLS for at least 15 nights per month.
•are otherwise in good general health.

Click here for more info. 

If you are interested in participating in this study, please CONTACT US.

Wake up to NEW narcolepsy research!

NeuroTrials Research is conducting a new, 4-week study evaluating the safety and efficacy of an investigational drug for excessive daytime sleepiness in individuals with narcolepsy.

To qualify, you must:
•be 18-65
•have a diagnosis of narcolepsy
•be in general good health
•have a typical bedtime before midnight

Click here for more info. 

If you are interested in participating in this study, please CONTACT US.

NeuroTrials Research is conducting a study to examine the effect of an investigational drug on sleep quality in patients with mild Alzheimer's Disease and cognitive impairment.

All study-related care and study drug will be provided at no cost. Qualified participants and caregivers will be compensated for time and travel.


You may qualify if you:
• are 50-80.
• have been diagnosed with Alzheimer’s Disease or mild cognitive impairment.
• have a caregiver or study partner capable of attending all study visits
• are otherwise in good general health with no sleep disorders.

Click here for more info. 

If you are interested in participating in this study, please CONTACT US.

NeuroTrials Research is conducting a research study on a NEW investigational drug for the pain and sleep problems commonly associated with painful diabetic neuropathy.

All study-related care and study drug will be provided at no cost, and qualified participants will be compensated for time and travel.


You may qualify if you:
• have a diagnosis of painful diabetic neuropathy.
• are 18-65.
• are otherwise in general good health.

Click here for more info. 

If you are interested in participating in this study, please CONTACT US.

NeuroTrials Research is conducting a study to examine a new treatment option during sleep for participants with chronic pain. Compensation is available for eligible participants.


You may qualify if:
• You are 21-70.
• You have a diagnosis ofchronic non- malignant pain (for ≥ 6 months.
• You follow a stable regimen of opioids for chronic pain for at least 4 wks prior to study.
• You have NOT used a CPAP within the last 90 days.
• You have NOT had surgery involving the upper airway, eye, nose, sinuses, or middle ear within 90 days.
• You do NOT have a previous diagnosis of COPD.

Click here for more info. 

If you are interested in participating in this study, please CONTACT US.

Have sleep apnea? Wear a CPAP?

NeuroTrials Research is conducting a study to evaluate a positive airway pressure system against current CPAP treatments. Qualified participants receive all study-related exams and study treatment at no cost.

You may qualify if you:
•are 18-70
•are diagnosed with moderate to severe OSA
•have been using a prescribed CPAP for at least 30 days
•are otherwise in good general health

Click here for more info. 

If you are interested in participating in this study, please CONTACT US.

NeuroTrials Research is evaluating the effect of an investigational weight loss drug, in combination with a personalized diet & exercise program, on the severity of obstructive sleep apnea (OSA).

All study-related care and study drug will be provided at no cost, and qualified participants will be compensated for time and travel.


You may qualify if you:
• have a diagnosis of moderate to severe obstructive sleep apnea.
• are 18-64.
• are unable or unwilling to use a CPAP or other similar device
• are overweight

Click here for more info. 

If you are interested in participating in this study, please CONTACT US.